Pure Global
NCT05990764

Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)

AronPharma Sp. z o. o.·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
IBS - Irritable Bowel Syndrome
Drug/Device/Intervention
Probiotic, Prebiotic, Polyphenol-rich Extracts
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
AronPharma Sp. z o. o.
Location
Poznań, Poland
Timeline & enrollment
Phase
N/A
Start date
May 08, 2023
End date
Sep 30, 2023
Enrollment
48 participants
Primary outcome

IBS-QoL (Irritable Bowel Syndrome-Quality of Life) index,Stool consistency

Summary

The aim of the study is to demonstrate a beneficial effect in reducing symptoms that
 negatively affect the quality of life of IBS patients, and to demonstrate a positive effect
 on inflammatory and intestinal function markers.

ICD-10 classifications
Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05990764
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05990764 through Pure Global AI's free database. This phase not specified trial is sponsored by AronPharma Sp. z o. o. and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 48 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.